New York Breast Imaging Society 2024/2025

Sunday, September 1, 2024, 6:00 PM - 8:00 PM, Online, New York, NY


The New York Breast Imaging Society is a non-profit professional organization committed to providing a forum for discussion of current and evolving practices and technologies in breast imaging for radiologists and technologists. Dues-paying members from the New York City and tri-state area participate in 5 meetings per year that provide CME and ASRT accredited lectures on a variety of breast imaging topics by experts from the tri-state area. The focus continues to be inclusive of radiologists and technologists but also nurses and trainees. The evolution of lecture topics over the years reflects exciting progress in breast imaging, from advances in MRI to the development of tomosynthesis and contrast enhanced mammography.

1. Discuss the latest science in breast cancer
2. Review the latest in breast imaging interpretation and technology
3. Examine techniques for being effective breast imagers

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Memorial Sloan Kettering Cancer Center and the New York Breast Imaging Society. Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

 

AMA Credit Designation Statement 

MSK designates this live activity for a maximum of 10  AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity. 

Mitigation of Relevant Financial Relationships

Memorial Sloan Kettering Cancer Center adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.